Trapelo is the result of nearly a decade of collaboration by an expert team of scientists, clinicians and information technologists.

Their ongoing work designing and curating a knowledgebase of all genes, targeted agents and published evidence helps oncologists identify up front precisely what should be tested and for which patients. Trapelo allows oncologists to order such tests from their preferred labs, and then synthesizes the results into standardized, actionable reports. Treatment options are ranked according to levels of evidence, empowering oncologists to make faster, more informed choices with confidence. 


Trapelo's independent validation of appropriate use of molecular testing and targeted treatment selection can be made available to participating payors automatically, obviating the need for traditional prior authorization for labs and providers.

Learn more about what Trapelo knows:

Which patients to test, which panels to order, and which labs to use
For Oncologists
How to standardize value-based precision medicine across the practice
For Practices
How to drive volume and enhance reimbursement
For Labs
Which tests and treatments are evidence-supported and should be reimbursed
For Payers

Why Standardizing Precision Medicine Decision Support Should Be a Top Priority for Cancer Centers of Every Size


From Possibility to Clinical Imperative:

How can we resolve the complexities of using precision medicine for cancer care?

Trapelo knows.

Request A Demo
See How Trapelo Can Work For You

Name *

Email *




PHONE  617.250.7572

FAX  888.972.5991


800 District Ave, Suite 310
Burlington, MA 01803

Google Map »

Copyright 2020 Trapelo Health. All rights reserved. Privacy Policy